We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
In 2016, Polpharma Biologics acquired Dutch based Bioceros and their proprietary cell line development platform CHOBC, as well as their discovery, process development and analytical capabilities.